Noble Partners

Latest statistics and disclosures from Noble Partners's latest quarterly 13F-HR filing:

Companies in the Noble Partners portfolio as of December 2011 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Us Natural Gas Fd Etf 20.51 450000 -50% 6.46
GOLAR LNG Limited Com 10.81 50000 NEW 30.66
Ariad Pharmaceuticals (ARIA) 7.34 85000 +112% 12.25
Jazz Pharmaceuticals (JAZZ) 6.81 25000 +257% 38.64
Pacific Ethanol Inc 6.73 900000 NEW 1.06
Allergan (AGN) 6.19 10000 -9% 87.70
Elan Corporation (ELN) 4.85 50000 +25% 13.74
Celgene Corporation (CELG) 4.77 10000 NEW 67.60
NPS Pharmaceuticals (NPSP) 3.95 85000 NEW 6.59
Akorn (AKRX) 3.92 50000 -61% 11.12
Johnson & Johnson (JNJ) 3.70 8000 NEW 65.62
Vertex Pharmaceuticals Incorporated (VRTX) 3.51 15000 NEW 33.20
Optimer Pharmaceuticals (OPTR) 3.46 40000 NEW 12.25
Amarin Corporation (AMRN) 3.17 60000 +100% 7.48
Insulet Corporation (PODD) 2.66 20000 NEW 18.85
Inhibitex (INHX) 2.31 30000 NEW 10.93
Perrigo Company (PRGO) 2.06 3000 -62% 97.33
Green Plains Renewable Energy (GPRE) 1.38 20000 NEW 9.75
Community Health Systems (CYH) 1.23 10000 NEW 17.50
Cardiome Pharma Corp 0.49 26100 -72% 2.64
ACADIA Pharmaceuticals (ACAD) 0.16 20000 1.10

Past 13F-HR SEC Filings by Noble Partners

View All Filings